Published online before print March 24, 2005, doi: 10.1161/01.ATV.0000163845.07146.48
© 2005 American Heart Association, Inc.
Thrombosis |
Analysis of Gas6 in Human Platelets and Plasma
From the Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Wallenberg Laboratory, University Hospital Malmö, Sweden. Present address for I.B. is the Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Hungary.
Correspondence to Björn Dahlbäck MD, PhD, Professor of Blood Coagulation Research, University of Lund, Department of Laboratory Medicine, Division of Clinical Chemistry, Wallenberg laboratory, University Hospital, Malmö, S-20502 Malmö, Sweden. E-mail bjorn.dahlback{at}klkemi.mas.lu.se
Objective— Gas6 is a member of the vitamin K-dependent protein family. Gas6-deficient mice were found to be resistant to thrombosis because of defective platelet function. Mouse Gas6 was demonstrated to be present in platelets and found to be involved in platelet aggregation. The aim of this study was to investigate the presence of Gas6 in human platelets and plasma and determine its role in platelet function.
Methods and Results— The presence of Gas6 in human platelets and plasma was analyzed using sensitive immunologic methods. Mass spectrometry and ELISA were used to identify and quantify Gas6 in plasma. Gas6 was demonstrated to be present in human plasma, at a concentration determined to be 13 to 23 ng/mL (0.16 to 0.28 nM). Furthermore, plasma Gas6 levels were found to be lower in patients administered with warfarin. However, Gas6 was undetectable in human platelets.
Conclusions— This is the first report to identify and quantify Gas6 in human plasma. However, Gas6 protein was not detected in human platelets, suggesting that any potential platelet-specific function could be because of Gas6 from the circulation. These findings open up new directions regarding the role of Gas6 in normal and pathophysiological situations such as inflammation, autoimmune disease, thrombosis and arteriosclerosis.
The aim of this study was to analyze the presence of Gas6 in human plasma and platelets. Using sensitive immune-based methods, we detected Gas6 in the human circulation in the sub-nanomolar range, the concentration of which was slightly decreased in warfarin-treated patients. However, we could not detect Gas6 in human platelets.
Key Words: Gas6 • protein S • vitamin K • Gla • warfarin • platelets
This article has been cited by other articles:
 |
|
 |
|
  J.-K. Park, S. Theuer, T. Kirsch, C. Lindschau, U. Klinge, A. Heuser, R. Plehm, M. Todiras, P. Carmeliet, H. Haller, et al. Growth Arrest Specific Protein 6 Participates in DOCA-Induced Target-Organ Damage Hypertension, August 1, 2009; 54(2): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gustafsson, D. Martuszewska, M. Johansson, C. Ekman, S. Hafizi, B. Ljungberg, and B. Dahlback Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival Clin. Cancer Res., July 15, 2009; 15(14): 4742 - 4749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rivera, M. L. Lozano, L. Navarro-Nunez, and V. Vicente Platelet receptors and signaling in the dynamics of thrombus formation Haematologica, May 1, 2009; 94(5): 700 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Liao, X. Wang, M. Li, P. H. Lin, Q. Yao, and C. Chen Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages Blood, January 1, 2009; 113(1): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Borgel Gas6 inflames cell interactions Blood, April 15, 2008; 111(8): 3915 - 3915. [Full Text] [PDF]
|
|
|
|
|
|
M. Tjwa, L. Bellido-Martin, Y. Lin, E. Lutgens, S. Plaisance, F. Bono, N. Delesque-Touchard, C. Herve, R. Moura, A. D. Billiau, et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes Blood, April 15, 2008; 111(8): 4096 - 4105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Brass, L. Zhu, and T. J. Stalker Novel Therapeutic Targets at the Platelet Vascular Interface Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): s43 - s50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Hers Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3K{alpha} pathway Blood, December 15, 2007; 110(13): 4243 - 4252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Clauser, S. Peyrard, P. Gaussem, M. Crespin, J. Emmerich, M. Aiach, and D. Borgel Development of a Novel Immunoassay for the Assessment of Plasma Gas6 Concentrations and Their Variation with Hormonal Status Clin. Chem., October 1, 2007; 53(10): 1808 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. J.H. Sachs and B. Nieswandt In Vivo Thrombus Formation in Murine Models Circ. Res., April 13, 2007; 100(7): 979 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D.M. Collett, A. P. Sage, J. P. Kirton, M. Y. Alexander, A. P. Gilmore, and A. E. Canfield Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells Circ. Res., March 2, 2007; 100(4): 502 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Graham, D. B. Salzberg, J. Kurtzberg, S. Sather, G. K. Matsushima, A. K. Keating, X. Liang, M. A. Lovell, S. A. Williams, T. L. Dawson, et al. Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia. Clin. Cancer Res., May 1, 2006; 12(9): 2662 - 2669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Clauser, C. Bachelot-lozat, P. Fontana, P. Gaussem, V. Remones, M. Aiach, and D. Borgel Physiological plasma Gas6 levels do not influence platelet aggregation. Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): e22 - e22. [Full Text] [PDF]
|
|